Myeloma Center
425 East 61st Street
8th Floor
New York, NY 10065
New and Existing Patients
Already a patient?
Login or sign-upto Connect Patient Portal to make an appointment
Locations and Appointments
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
AETNA
Aetna - NYP
Amida Care
Anthem Blue Cross Blue Shield
Anthem Blue Cross/Blue Shield
Anthem Blue Cross/Blue Shield Healthplus
CIGNA
EmblemHealth
Fidelis Care
GHI
Health Insurance Plan of NY (HIP)
Healthfirst
Healthspring
Local 1199
Molina Healthcare
Oxford Health Plans
Quality Health Management (QHM)
Rockefeller University/Luminare
United Healthcare
UnitedHealthcare
VNS Health
VNSNY CHOICE
WellCare
WorldWide Medical
About Mateo Mejia Saldarriaga, M.D.
Dr. Mateo Mejia is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital.
Dr. Mejia received his medical degree (M.D.) from the Universidad CES in his hometown of Medellin, Colombia, after which he completed an internal medicine residency at the Jacobi Medical Center/Albert Einstein College of Medicine in the Bronx, NY, where he also served as a Chief Resident. He completed his Hematology and Oncology fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital and joined the Hematology and Medical Oncology Division after completing his fellowship tra...
Board Certifications
- Internal Medicine
Education
- Degrees: Institute of Health Sciences, CES, Faculty of Medicine (Colombia)
Languages
- English
- Spanish
Titles & Positions
- Assistant Attending Physician
- Assistant Professor of Medicine
- Charles, Lillian and Betty Neuwirth Clinical Scholar in Oncology
Hospital Affiliations
- NewYork-Presbyterian / Weill Cornell Medical Center
- NewYork-Presbyterian Lower Manhattan Hospital
Education
- Degrees: Institute of Health Sciences, CES, Faculty of Medicine (Colombia)
Titles & Positions
- Assistant Attending Physician
- Assistant Professor of Medicine
- Charles, Lillian and Betty Neuwirth Clinical Scholar in Oncology
Board Certifications
- internal medicine
Languages Spoken
- english
- spanish
NYP Articles & Features
Dr. Mateo Mejia Saldarriaga: Biomarker Predicts Response to BCMA CAR T-Cell Therapy in Multiple Myeloma
Advances•June 13, 2025Predicting Response to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma
Advances•October 09, 2024
Research
Abnormal serum immunofixation patterns are common after BCMA CAR-T in multiple myeloma and are preceded by immune events.
July 03, 2026Real-World Assessment of Prophylactic Anakinra on Neurotoxicity and Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory B-Cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis.
June 17, 2026Morphologic and immunophenotypic characterization of lymphocytosis following BCMA-targeted CAR-T cell therapy in relapsed/refractory multiple myeloma.
January 29, 2026